Right-In-Time Clinical Trials
Caris Life Sciences Right-In-Time clinical trial network eliminates repetitive contracting, feasibility and site qualification activities so providers can focus on treating their patients, rather than the administrative burden of clinical trial start-up. The Caris team works with the site to develop, review and submit required regulatory paperwork and documentation.
Right-In-Time Clinical Trial Network
As the Right-In-Time (RIT) clinical trial pioneer, with more than 20 years of oncology clinical trial experience, Caris RIT is a research system designed to rapidly identify and enroll patients into clinical trials in about two weeks, and as little as five days. With a robust portfolio of clinical trials with leading biopharmaceutical companies, this innovative system reduces the burden on research facilities and physicians while increasing patient access to a larger number of potential treatment options.
575+
Locations
2,200+
Trial Investigators
50K+
Patients Identified
80+
Biopharma Relationships
30+
Clinical Trials
The Caris Difference – Personalized Trial Matching with Caris Clinical Trial Navigators (CTNs)
Caris’ Clinical Trial Navigators (CTNs) are a team of registered nurses specially trained to identify and pre-screen patients for oncology clinical trials. CTNs match patients’ CMI biomarker results to clinical trials offered through Caris’s MI Trials program. CTNs provide a hands-on service that includes trial matching, screening for eligibility, and navigating trial logistics to connect patients to the nearest open study site. If a patient isn’t ready to enroll in a clinical trial when the CTN speaks to the physician, the CTN can work with the oncologist to track patients until progression and when the clinical trial therapy is needed.
How it Works
Based on results of molecular testing, the Caris RIT system quickly matches patients to potential clinical trials and then accelerates site activation for patient enrollment at the local institution, right in the patient’s community. Molecular testing information from any provider may be used to identify potential trial opportunities, the process is supercharged with molecular testing performed by Caris Life Sciences because of the seamless integration of molecular data.
PATIENT-TRIAL MATCH PROCESS
Day 1
Caris Comprehensive Genomic Profiling performed on patient.
Day 2
Clinical Trial Navigator (CTN) determines patient-trial match. CTN contacts physician for matched RIT clinical trial.
Day 3-12
Local Right-In-Time site activation.
Day 13-14
Patient enrolled in local clinical trial.
Studies have demonstrated that continuity of care has a direct positive correlation to outcomes and improved quality of clinical care. Patients within the Caris RIT oncology network gain access to innovative molecular diagnostics while remaining in the care of their current treatment team, locally. Continuity of care assists in eliminating the added stressors of extended travel times to clinical trial sites and unfamiliarity of new health care providers.
Join the largest trial-ready network
The Caris Right-In-Time Network is a network of over 575 locations throughout United States and Puerto Rico who have immediate and on-going access to a portfolio of trials for their patients. Caris Right-In-Time site registration and regulatory documentation are streamlined, accelerating trial activation in as little as 14 days. This patient centric approach also allows the patient to remain under the care of their treating oncologist and eliminates the burden of travel for the patient.
Join the Largest Trial-Ready Network
Discover
More
Caris performs artificial intelligence (AI)-enhanced comprehensive molecular profiling to help healthcare providers make more personalized treatment decisions for their patients.
The Caris Molecular Tumor Board provides oncologists with the opportunity to interact with leading cancer experts from across the country to obtain interpretation of molecular findings and therapeutic guidance for individual patients.